Turkish Version of Telehealth Usability Questionnaire (TUQ)

December 2, 2023 updated by: Irem Hüzmeli

Investigation of the Turkish Validity and Reliability of the Telehealth Usability Questionnaire (TUQ)

The Telehealth Usability Questionnaire (TUQ) was developed to evaluate the usability of telehealth applications and services. The Turkish validity and reliability study of the scale, originally in English, has not been conducted before.

The aim of this study is to develop the Turkish version of the Telehealth Usability Questionnaire (TUQ), which is a new stability tool, and to report its reliability assessment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The Telehealth Usability Questionnaire (TUQ) turkish version will be asked by using google forms to participants whom use telehealth.

Study Type

Observational

Enrollment (Actual)

170

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Hatay, Turkey
        • Online
    • Merkez
      • Hatay, Merkez, Turkey, 31010
        • Hatay Mustafa Kemal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The Turkish validity and reliability of the scale, which was created to evaluate the usability of the telehealth service for service users (patients) and providers (health professional), will be investigated.

Description

Inclusion Criteria:

Participants will undergo screening to confirm eligibility, completion of initial screening form, and MMSE evaluation. Study subjects were enrolled with MMSE scores between 29-30, inclusive (healthy/control), 25-28, inclusive (mild cognitive impairment), and 10-24 (dementia).

-

Exclusion Criteria:

  • Unable to complete computerized and standard pencil-and-paper based assessments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patients
patients who were used telehealth
Procedure: validity and reability study
validity and reliability assessment of the Turkish version of the Telehealth Usability Questionnaire (TUQ)
health professional
health professional who were used telehealth.
Procedure: validity and reability study
validity and reliability assessment of the Turkish version of the Telehealth Usability Questionnaire (TUQ)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reliability and Validity of TUQ by Correlation Analysis.
Time Frame: 12 month
with telehealth will be researched
12 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Irem Hüzmeli

Investigators

  • Study Director: Irem Huzmeli, PhD, Mustafa Kemal University
  • Principal Investigator: Esra Dogru Huzmeli, Assoc Prof., Mustafa Kemal University
  • Study Chair: Mehmet Karadağ, Asist. Prof., Mustafa Kemal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 12, 2021

Primary Completion (Actual)

June 12, 2022

Study Completion (Actual)

June 12, 2022

Study Registration Dates

First Submitted

March 14, 2021

First Submitted That Met QC Criteria

March 14, 2021

First Posted (Actual)

March 17, 2021

Study Record Updates

Last Update Posted (Estimated)

December 5, 2023

Last Update Submitted That Met QC Criteria

December 2, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HatayMustafaKU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Participation

Clinical Trials on validity and reability study

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe